Product image of Levocetirizine Dihcl Viatris (Levocetirizine Dihydrochloride) supplied by GNH India

Levocetirizine Dihcl Viatris

Active Ingredient:
Levocetirizine Dihydrochloride
Origin:
EU

Levocetirizine Dihcl Viatris (Levocetirizine Dihydrochloride)

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Dihcl Viatris, is an antihistamine (H1 receptor antagonist) presented as an oral tablet for oral use. It alleviates symptoms of allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH India supplies Levocetirizine Dihcl Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levocetirizine Dihcl Viatris is an H1‑antihistamine used to manage allergic conditions.
  • Allergic rhinitis: reduces nasal congestion, itching and watery discharge.
  • Chronic idiopathic urticaria: diminishes wheal formation and itching.
  • Other IgE‑mediated allergic conditions: may provide symptomatic relief of mild skin or nasal symptoms.

How It Works

  • Levocetirizine Dihydrochloride selectively blocks peripheral H1 receptors, preventing histamine from binding to its target cells. By inhibiting this interaction, it reduces the vascular permeability, sensory nerve activation and glandular secretion that underlie the classic signs of an allergic response, leading to relief of itching, swelling, and rhinorrhea.

Side Effects

Levocetirizine Dihcl Viatris is generally well tolerated.

Common Side Effects

  • Drowsiness: mild sedation, especially at treatment initiation.
  • Headache: transient, often resolves without intervention.
  • Dry mouth: mild reduction in salivary flow.
  • Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips or tongue requiring urgent care.
  • Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Anaphylaxis: rare systemic allergic reaction with respiratory compromise.
  • Hepatic injury: abnormal liver enzymes, monitor if clinically indicated.
  • Blood dyscrasias: rare cases of neutropenia or thrombocytopenia.

Precautions & Warnings

  • Levocetirizine Dihcl Viatris should be used with caution in certain populations and conditions.
  • Pregnancy: safety not established; use only if clearly needed.
  • Breastfeeding: limited data; weigh potential benefits against risks.
  • Renal impairment: dose may require adjustment in severe dysfunction.
  • Elderly: increased susceptibility to sedation; monitor functional status.
  • Drug interactions: review concomitant medications for potential additive effects.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Levocetirizine Dihcl Viatris may interact with other medicines.

Major Interactions (Avoid)

  • Ketoconazole: may increase levocetirizine plasma concentrations.
  • Erythromycin: potential elevation of drug levels.
  • Ritonavir: can raise systemic exposure.

Moderate Interactions (Monitor Closely):\n- Alcohol: may enhance drowsiness and impair coordination.

  • Other antihistamines: additive sedation risk.
  • CNS depressants: increased central nervous system effects.

Frequently Asked Questions

Levocetirizine Dihcl Viatris contains levocetirizine dihydrochloride, an H1‑antihistamine indicated for the symptomatic relief of allergic rhinitis and chronic idiopathic urticaria. It helps reduce nasal congestion, itching, sneezing, and skin wheal formation associated with these allergic conditions.

Levocetirizine selectively blocks peripheral H1 receptors, preventing histamine from binding to its target cells. This inhibition reduces vascular permeability, sensory nerve activation, and glandular secretion, thereby alleviating the classic signs of an allergic reaction such as itching, swelling, and rhinorrhea.

The appropriate dose of Levocetirizine Dihcl Viatris is determined by the prescribing healthcare professional based on the patient’s age, clinical condition, renal function, and other individual factors. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for levocetirizine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a potentially lower incidence of sedation. Compared with first‑generation antihistamines, it provides effective allergy relief with fewer anticholinergic side effects, making it a preferred option for many patients requiring once‑daily dosing.

The product should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not use if the tablet shows signs of damage or discoloration.

Levocetirizine Dihcl Viatris is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with water and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious but rare risks include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, hepatic injury, and hematologic abnormalities like neutropenia. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, or signs of an allergic reaction.

Levocetirizine should be avoided in individuals with known hypersensitivity to levocetirizine or any component of the formulation. Caution is advised for patients with severe renal impairment, pregnant or breastfeeding women, and those taking medications that may significantly increase levocetirizine levels without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.